News Reader
02-19-2009, 03:47 PM
The U.S. Food and Drug Administration today approved a humanitarian device exemption for the first implantable device that delivers intermittent electrical therapy deep within the brain to suppress the symptoms associated with severe obsessive-compulsive disorder (OCD).
More... (http://www.fda.gov/bbs/topics/NEWS/2009/NEW01959.html)
More... (http://www.fda.gov/bbs/topics/NEWS/2009/NEW01959.html)